Sugi Predict

Sugi Predict / Compounds / SCHEMBL29416121

SCHEMBL29416121

SCHEMBL29416121

CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)[C@@H](C)O)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 14/20 0.56
▸ BACE2 Q9Y5Z0 4/20 0.56
▸ OPRM1 P35372 4/20 0.56
▸ OPRD1 P41143 4/20 0.56
▸ OPRK1 P41145 1/20 0.55
▸ CTSD P07339 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29415987 1.00 BACE1 (0.56) BACE1BACE2OPRM1OPRD1OPRK1
SCHEMBL29416179 0.91 BACE1 (0.63) BACE1BACE2CTSD
SCHEMBL31174213 0.91 BACE1 (0.56) BACE1BACE2CTSD
SCHEMBL29602768 0.90 OPRM1 (0.62) BACE1BACE2OPRM1OPRD1OPRK1
SCHEMBL29409626 0.88 BACE1 (0.59) BACE1BACE2CTSD
SCHEMBL30646305 0.88 BACE1 (0.64) BACE1BACE2CTSD
SCHEMBL30901008 0.87 BACE1 (0.59) BACE1BACE2CTSD
SCHEMBL30296833 0.87 OPRM1 (0.54) BACE1BACE2OPRM1OPRD1OPRK1
SCHEMBL29625263 0.86 FNTA (0.62) BACE1BACE2CTSD
SCHEMBL30658359 0.85 OPRM1 (0.61) BACE1BACE2OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110381984-B Compositions and methods for improving sexual function 尼莫克斯股份有限公司 2023-11-28 — — CN disclosed
EP-4275688-A2 METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH Nymox Corporation (BS) 2023-11-15 — — EP disclosed
CN-116785403-A Neurofilament peptides for preventing or slowing the progression of prostate cancer 尼莫克斯股份有限公司 2023-09-22 — — CN disclosed
CN-109310732-B Neurofilament peptides for preventing or slowing the progression of prostate cancer 尼莫克斯股份有限公司 2023-07-21 — — CN disclosed
US-11628202-B2 Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia NYMOX CORPORATION (CA) 2023-04-18 — — US disclosed
CN-114099636-A Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins 尼莫克斯制药公司 2022-03-01 — — CN disclosed
Send feedback